Publication | Closed Access

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Regenerative MedicineMesenchymal Stem CellsCell TherapyMedicineImmunologyClinical TrialsStem Cell ResearchStem-cell TherapyBiomedical EngineeringMultiple SclerosisStem CellsMesenchymal Stem CellDouble-blind Crossover TrialHealth Sciences